Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt 0.09
GNC's Cash to Debt is ranked lower than
51% of the 500 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.65 vs. GNC: 0.09 )
GNC' s 10-Year Cash to Debt Range
Min: 0.06   Max: No Debt
Current: 0.09

Equity to Asset 0.28
GNC's Equity to Asset is ranked higher than
56% of the 506 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.42 vs. GNC: 0.28 )
GNC' s 10-Year Equity to Asset Range
Min: 0.24   Max: 0.42
Current: 0.28

0.24
0.42
Interest Coverage 10.74
GNC's Interest Coverage is ranked higher than
63% of the 369 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 13.64 vs. GNC: 10.74 )
GNC' s 10-Year Interest Coverage Range
Min: 2.02   Max: 10.74
Current: 10.74

2.02
10.74
F-Score: 7
Z-Score: 3.20
M-Score: -2.58
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 17.51
GNC's Operating margin (%) is ranked higher than
98% of the 506 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 3.67 vs. GNC: 17.51 )
GNC' s 10-Year Operating margin (%) Range
Min: 10.24   Max: 17.61
Current: 17.51

10.24
17.61
Net-margin (%) 10.08
GNC's Net-margin (%) is ranked higher than
96% of the 506 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 2.15 vs. GNC: 10.08 )
GNC' s 10-Year Net-margin (%) Range
Min: 3.3   Max: 10.08
Current: 10.08

3.3
10.08
ROE (%) 32.49
GNC's ROE (%) is ranked higher than
97% of the 496 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 10.58 vs. GNC: 32.49 )
GNC' s 10-Year ROE (%) Range
Min: 8.36   Max: 32.49
Current: 32.49

8.36
32.49
ROA (%) 9.67
GNC's ROA (%) is ranked higher than
93% of the 506 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 4.35 vs. GNC: 9.67 )
GNC' s 10-Year ROA (%) Range
Min: 2.38   Max: 9.67
Current: 9.67

2.38
9.67
ROC (Joel Greenblatt) (%) 65.32
GNC's ROC (Joel Greenblatt) (%) is ranked higher than
96% of the 505 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 19.49 vs. GNC: 65.32 )
GNC' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 35.18   Max: 69.2
Current: 65.32

35.18
69.2
Revenue Growth (%) 9.60
GNC's Revenue Growth (%) is ranked higher than
87% of the 448 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 4.60 vs. GNC: 9.60 )
GNC' s 10-Year Revenue Growth (%) Range
Min: 0   Max: 9.6
Current: 9.6

0
9.6
EBITDA Growth (%) 20.90
GNC's EBITDA Growth (%) is ranked higher than
94% of the 401 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 5.00 vs. GNC: 20.90 )
GNC' s 10-Year EBITDA Growth (%) Range
Min: 0   Max: 20.9
Current: 20.9

0
20.9
EPS Growth (%) 47.40
GNC's EPS Growth (%) is ranked higher than
98% of the 378 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 5.50 vs. GNC: 47.40 )
GNC' s 10-Year EPS Growth (%) Range
Min: 0   Max: 58.1
Current: 47.4

0
58.1
» GNC's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2013

GNC Guru Trades in Q3 2013

Jim Simons 320,100 sh (+148.72%)
John Keeley 209,580 sh (+38.26%)
Steven Cohen 2,691,891 sh (+5.41%)
Columbia Wanger 2,569,200 sh (unchged)
Mario Gabelli 11,400 sh (unchged)
Louis Moore Bacon Sold Out
RS Investment Management 804,598 sh (-19.06%)
Joel Greenblatt 49,230 sh (-41.33%)
» More
Q4 2013

GNC Guru Trades in Q4 2013

Caxton Associates 6,344 sh (New)
Paul Tudor Jones 27,563 sh (New)
Joel Greenblatt 155,608 sh (+216.08%)
Columbia Wanger 2,569,200 sh (unchged)
John Keeley 209,030 sh (-0.26%)
Mario Gabelli 10,500 sh (-7.89%)
RS Investment Management 695,403 sh (-13.57%)
Jim Simons 122,500 sh (-61.73%)
Steven Cohen 321,936 sh (-88.04%)
» More
Q1 2014

GNC Guru Trades in Q1 2014

Joel Greenblatt 364,031 sh (+133.94%)
RS Investment Management 1,243,648 sh (+78.84%)
Paul Tudor Jones 39,787 sh (+44.35%)
Mario Gabelli 13,470 sh (+28.29%)
John Keeley 218,460 sh (+4.51%)
Caxton Associates Sold Out
Columbia Wanger 2,568,400 sh (-0.03%)
Jim Simons 98,700 sh (-19.43%)
Steven Cohen 4,955 sh (-98.46%)
» More
Q2 2014

GNC Guru Trades in Q2 2014

Richard Snow 15,400 sh (New)
Louis Moore Bacon 30,000 sh (New)
Jim Simons 343,000 sh (+247.52%)
Joel Greenblatt 861,384 sh (+136.62%)
Mario Gabelli 16,205 sh (+20.3%)
RS Investment Management 1,275,693 sh (+2.58%)
John Keeley Sold Out
Columbia Wanger 1,640,600 sh (-36.12%)
Paul Tudor Jones 10,394 sh (-73.88%)
» More
» Details

Insider Trades

Latest Guru Trades with GNC

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Joel Greenblatt 2014-06-30 Add 136.62%0.21%$33.86 - $46.86 $ 37.95-5%861384
John Keeley 2014-06-30 Sold Out 0.17%$33.86 - $46.86 $ 37.95-5%0
Mario Gabelli 2014-06-30 Add 20.3%$33.86 - $46.86 $ 37.95-5%16205
Joel Greenblatt 2014-03-31 Add 133.94%0.14%$43.2 - $58.45 $ 37.95-24%364031
Mario Gabelli 2014-03-31 Add 28.29%$43.2 - $58.45 $ 37.95-24%13470
Joel Greenblatt 2013-12-31 Add 216.08%0.15%$53 - $60.56 $ 37.95-34%155608
Joel Greenblatt 2013-09-30 Reduce -41.33%0.07%$45.88 - $54.5 $ 37.95-26%49230
John Keeley 2013-09-30 Add 38.26%0.06%$45.88 - $54.5 $ 37.95-26%209580
John Keeley 2013-06-30 New Buy0.13%$38.88 - $47.93 $ 37.95-14%151580
Mario Gabelli 2013-06-30 Add 111.11%$38.88 - $47.93 $ 37.95-14%11400
Joel Greenblatt 2013-03-31 Add 92.61%0.1%$32.2 - $42.19 $ 37.951%100048
Mario Gabelli 2013-03-31 New Buy$32.2 - $42.19 $ 37.951%5400
Joel Greenblatt 2012-12-31 Add 135.04%0.06%$32.6 - $40.72 $ 37.955%51943
Joel Greenblatt 2012-09-30 New Buy0.06%$35.74 - $42.41 $ 37.95-2%22100
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 13.60
GNC's P/E(ttm) is ranked higher than
90% of the 520 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 21.20 vs. GNC: 13.60 )
GNC' s 10-Year P/E(ttm) Range
Min: 11.75   Max: 31.9
Current: 13.6

11.75
31.9
P/B 4.50
GNC's P/B is ranked lower than
59% of the 520 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 2.07 vs. GNC: 4.50 )
GNC' s 10-Year P/B Range
Min: 2.17   Max: 6.88
Current: 4.5

2.17
6.88
P/S 1.30
GNC's P/S is ranked lower than
61% of the 520 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.49 vs. GNC: 1.30 )
GNC' s 10-Year P/S Range
Min: 0.92   Max: 2.3
Current: 1.3

0.92
2.3
PFCF 17.70
GNC's PFCF is ranked higher than
89% of the 519 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 162.00 vs. GNC: 17.70 )
GNC' s 10-Year PFCF Range
Min: 12.82   Max: 34.5
Current: 17.7

12.82
34.5
EV-to-EBIT 10.21
GNC's EV-to-EBIT is ranked higher than
88% of the 520 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 15.76 vs. GNC: 10.21 )
GNC' s 10-Year EV-to-EBIT Range
Min: 9.2   Max: 15.2
Current: 10.21

9.2
15.2
PEG 0.68
GNC's PEG is ranked higher than
98% of the 520 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 155.00 vs. GNC: 0.68 )
GNC' s 10-Year PEG Range
Min: 0   Max: 0.8
Current: 0.68

0
0.8
Current Ratio 3.42
GNC's Current Ratio is ranked higher than
97% of the 382 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.23 vs. GNC: 3.42 )
GNC' s 10-Year Current Ratio Range
Min: 2.88   Max: 3.91
Current: 3.42

2.88
3.91
Quick Ratio 1.17
GNC's Quick Ratio is ranked higher than
88% of the 382 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.71 vs. GNC: 1.17 )
GNC' s 10-Year Quick Ratio Range
Min: 0.93   Max: 1.85
Current: 1.17

0.93
1.85

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 1.70
GNC's Dividend Yield is ranked lower than
51% of the 431 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.80 vs. GNC: 1.70 )
GNC' s 10-Year Dividend Yield Range
Min: 0.27   Max: 1.9
Current: 1.7

0.27
1.9
Dividend Payout 0.22
GNC's Dividend Payout is ranked higher than
84% of the 520 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.56 vs. GNC: 0.22 )
GNC' s 10-Year Dividend Payout Range
Min: 0.18   Max: 0.3
Current: 0.22

0.18
0.3
Yield on cost (5-Year) 1.70
GNC's Yield on cost (5-Year) is ranked lower than
54% of the 436 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.97 vs. GNC: 1.70 )
GNC' s 10-Year Yield on cost (5-Year) Range
Min: 0.27   Max: 1.9
Current: 1.7

0.27
1.9
Share Buyback Rate -3.10
GNC's Share Buyback Rate is ranked higher than
62% of the 338 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: -0.20 vs. GNC: -3.10 )
GNC' s 10-Year Share Buyback Rate Range
Min: 0   Max: -6.1
Current: -3.1

Valuation & Return

vs
industry
vs
history
Price/Median PS Value 0.80
GNC's Price/Median PS Value is ranked higher than
92% of the 520 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.12 vs. GNC: 0.80 )
GNC' s 10-Year Price/Median PS Value Range
Min: 0.59   Max: 1.3
Current: 0.8

0.59
1.3
Earnings Yield (Greenblatt) 9.80
GNC's Earnings Yield (Greenblatt) is ranked higher than
86% of the 494 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 6.70 vs. GNC: 9.80 )
GNC' s 10-Year Earnings Yield (Greenblatt) Range
Min: 6.6   Max: 10.8
Current: 9.8

6.6
10.8

Business Description

Industry: Retail - Defensive » Pharmaceutical Retailers
Compare: » details
Traded in other countries:IGN.Germany
GNC Holdings Inc is a global specialty retailer of health and wellness products, including VMHS products, sports nutrition products, and diet products. The Company's business segments include: Retail, Franchising and Manufacturing/Wholesale.
» More Articles for GNC

Headlines

Articles On GuruFocus.com
These Health Retailers Are Enticing Long-Term Bets Aug 06 2014 
GNC Could Generate a 55% Return May 08 2014 
Herbalife and GNC Are Good Investments, Here’s Why Apr 17 2014 
Top 5 Stocks from TPG-Axon Mar 21 2013 
Billionaire Steven Cohen Vitamins Up with GNC Mar 04 2013 
Generac Holdings: Umbrellas Sell Better on and After Rainy Days Nov 28 2012 
President and CEO of GNC Holdings Inc. Joe Fortunato Sold 50,000 Shares Aug 08 2012 
Weekly CFO Sells Highlight: USB, GNC, WWWW, GWRE, CRIS, CSL Apr 30 2012 
George Soros Buys 7.98% Stake in Digital River, Steven Cohen Buys 5.4% Stake in GNC Mar 30 2012 
Weekly CEO Sells Highlight: GNC Holdings, Prologis Inc, Intuit Inc, and Blackrock Inc. Feb 26 2012 

More From Our Partners
What To Sell: 3 Sell-Rated Dividend Stocks BPY, AGNC, PBF Aug 28 2014 - THESTREET

More From Other Websites
NYSE stocks posting largest percentage increases Aug 29 2014
GNC, Southern Copper And Others Insiders Have Been Buying Aug 25 2014
GNC CEO Shakeup Could Be a Healthy Sign for Investors Aug 25 2014
Top 5 Stocks With Big Insider Buying This Week Aug 23 2014
[$$] Charting the Market Aug 23 2014
How bull is playing GNC rebound Aug 22 2014
5 Stocks Insiders Love Right Now Aug 21 2014
GNC Rises Following Insider Buy Aug 20 2014
Major Insider Buying at GNC: A Key Gamble or a Dream? Aug 20 2014
GNC Holdings, Inc. Increases Share Repurchase Authorization to $500 million Aug 13 2014
Why GNC (GNC) Stock Is Gaining Today Aug 11 2014
Why GNC (GNC) Stock Is Climbing In Pre-Market Trading Today Aug 11 2014
Earth Science Tech Gears Up to Open Retail Location in Coral Gables Aug 08 2014
GNC HOLDINGS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD... Aug 08 2014
How Will GNC Holdings (GNC) Stock Be Affected By New Company Leadership? Aug 05 2014
GNC HOLDINGS, INC. Financials Aug 05 2014
GNC Names Talbots Executive Archbold as CEO Aug 05 2014
GNC Holdings, Inc. Names Michael G. Archbold CEO Aug 05 2014
GNC Launches In-store Fundraising Event to Support Pressley Ridge's Programs to Keep Children and... Aug 01 2014
Amazon in 25 years: Which retailers are safe? Jul 31 2014

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK